Generex Biotechnology Corporation (GNBT)

Recent filings

Generex Biotechnology Corporation releases salary data. CEO sees compensation fall -64% - Oct. 13, 2017

Entry into a Material Definitive - Aug. 29, 2017

Preliminary Proxy Soliciting materials - Aug. 8, 2017

Generex Biotechnology: In Combination With Ae37 In Patients With Triple-Negative Breast Cancer - Aug. 1, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 9 - Net (Loss)... - June 15, 2017

Departure of Directors or Certain - May 26, 2017

Termination of a Material Definitive - May 22, 2017

Entry into a Material Definitive - April 27, 2017

Other preliminary proxy statements - April 18, 2017

Symbol Change - April 10, 2017

Financial Statements and - March 31, 2017

Generex Biotechnology: Generex Announces $115M Convertible Preferred Stock Financing; First Tranche Satisfies Emmaus Deposit - March 29, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 - Net (Loss)... - March 22, 2017

Generex Biotechnology: Generex Announces Reverse Stock Split - March 17, 2017

Notification of inability to timely file Form 10-Q or 10-QSB - March 17, 2017

Deleted Symbol - March 14, 2017

Entry into a Material Definitive - March 6, 2017

Entry into a Material Definitive - Feb. 24, 2017

Statement of acquisition of beneficial ownership by individuals - Feb. 16, 2017

Generex Biotechnology: Generex Announces Elimination Of Outstanding Derivative Securities - Feb. 15, 2017

Financial Statements and - Jan. 25, 2017

Entry into a Material Definitive - Jan. 20, 2017

Entry into a Material Definitive - Jan. 20, 2017

Generex Biotechnology: Securities And Exchange Commission - Jan. 20, 2017

Tier Change - Jan. 19, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 – Net (Loss)... - Jan. 18, 2017

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Loss per Common... - Jan. 17, 2017

Tier Change - Jan. 14, 2017

Generex Biotechnology: Securities And Exchange Commission - Jan. 13, 2017

Tier Change - July 23, 2016

Generex Biotechnology Corporation's President & CEO just picked up 14,890,033 shares - Feb. 12, 2016

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 – Net (Loss)... - Jan. 14, 2016

OTCQB Certification - Dec. 1, 2015

Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine - Oct. 15, 2015

Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine - Oct. 15, 2015

Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. - Oct. 13, 2015

Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. - Oct. 13, 2015

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Loss per Common... - Oct. 9, 2015

Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. - Oct. 6, 2015

Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. - Oct. 6, 2015

Generex Announces Issuance of Buccal Cannabis White Paper - Oct. 1, 2015

Generex Announces Issuance of Buccal Cannabis White Paper - Oct. 1, 2015

Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems - Sept. 30, 2015

Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems - Sept. 30, 2015

Generex Announces Commencement of Buccal Leuprolide R&D Work - Sept. 8, 2015

Generex Announces Commencement of Buccal Leuprolide R&D Work - Sept. 8, 2015

Generex Announces Formalization of Buccal Cannabis Co-Development Plan - Sept. 2, 2015

Generex Announces Formalization of Buccal Cannabis Co-Development Plan - Sept. 2, 2015

Generex Announces Issuance of Buccal Insulin White Paper - Aug. 27, 2015

Generex Announces Issuance of Buccal Insulin White Paper - Aug. 27, 2015

Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project - Aug. 25, 2015

Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project - Aug. 25, 2015

Generex Biotechnology: Securities And Exchange Commission - Aug. 20, 2015

Generex Biotechnology Corporation just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 4, 2015

Generex Biotechnology Corporation Just Received a Notice of Effectiveness - July 31, 2015

General form for registration of securities under the Securities Act of 1933 - July 17, 2015

General form for registration of securities under the Securities Act of 1933 - July 17, 2015

Revised definitive proxy soliciting materials - July 14, 2015

Other definitive proxy statements - July 7, 2015

Preliminary Proxy Soliciting materials - June 25, 2015

Generex Biotechnology: Generex Announces Capital Investment - June 25, 2015

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 – Net Income... - June 5, 2015

Other preliminary proxy statements - June 2, 2015

Generex Biotechnology Corporation director just picked up 5,874,162 shares - April 27, 2015

Generex Biotechnology: Item 5.02. Departure Of Directors And Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers - April 7, 2015

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 – Net Income... - March 6, 2015

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 – Net Income... - Dec. 12, 2014

Annual report [Section 13 and 15(d), not S-K Item 405] - Oct. 17, 2014

Generex Biotechnology Corporation's President & CEO just picked up 470,726 shares - Oct. 8, 2014

Generex Biotechnology Corporation director just picked up 35,714 shares - Oct. 8, 2014

Generex Biotechnology Corporation director just picked up 35,714 shares - Oct. 8, 2014

Securities to be offered to employees in employee benefit plans - July 3, 2014

Quarterly report [Sections 13 or 15(d)] - June 6, 2014

Generex Biotechnology: Submission Of Matters To A Vote Of Security Holders - May 23, 2014

[Paper] - May 6, 2014

Revised definitive proxy soliciting materials - May 5, 2014

Generex Biotechnology Corporation just filed a prospectus, suggesting it plans to soon issue some securities - April 17, 2014

Generex Biotechnology Corporation Just Received a Notice of Effectiveness - April 16, 2014

Other definitive proxy statements - April 1, 2014

Generex Biotechnology: Generex Announces $2,075,000 Capital Investment - March 28, 2014

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 8 – Net Loss Pe... - March 7, 2014

Other preliminary proxy statements - March 4, 2014

Generex Biotechnology Corporation just filed a General Statement of acquisition of beneficial ownership - Feb. 14, 2014

Generex Biotechnology Corporation just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 7, 2014

Generex Biotechnology Corporation Just Received a Notice of Effectiveness - Feb. 7, 2014

General form for registration of securities under the Securities Act of 1933 - Jan. 24, 2014

Current report, item 3.02 - Jan. 10, 2014

Quarterly report [Sections 13 or 15(d)] - Dec. 9, 2013

Current report, items 5.02 and 9.01 - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Annual report [Section 13 and 15(d), not S-K Item 405] - Oct. 18, 2013

Prospectus [Rule 424(b)(3)] - July 25, 2013

Notice of Effectiveness - July 24, 2013

[Amend] - July 3, 2013

Sorry, no schedule available for this company

No known shareholders

Generex Biotechnology Corporation (GNBT)

140

cctranscripts

Oct. 13, 2017

Generex Biotechnology Corporation releases salary data. CEO sees compensation fall -64% http://www.conferencecalltranscripts.org/pink/summary?id=4222869

cctranscripts

Aug. 29, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=4098431

cctranscripts

Aug. 8, 2017

Preliminary Proxy Soliciting materials http://www.conferencecalltranscripts.org/pink/summary?id=4031517

cctranscripts

Aug. 1, 2017

Generex Biotechnology: In Combination With Ae37 In Patients With Triple-Negative Breast Cancer http://www.conferencecalltranscripts.org/pink/summary?id=4007924

cctranscripts

June 15, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 9 - Net (Loss)... http://www.conferencecalltranscripts.org/pink/summary?id=3890542

cctranscripts

May 26, 2017

Departure of Directors or Certain http://www.conferencecalltranscripts.org/pink/summary?id=3834507

cctranscripts

May 22, 2017

Termination of a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3816598

cctranscripts

April 27, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3730264

cctranscripts

April 18, 2017

Other preliminary proxy statements http://www.conferencecalltranscripts.org/pink/summary?id=3697429

cctranscripts

April 10, 2017

Symbol Change http://www.otcmarkets.com/market-activity/corpActions.jsp?index=1&symbol=GNBTD&actionDate=1491800406000

cctranscripts

March 31, 2017

Financial Statements and http://www.conferencecalltranscripts.org/pink/summary?id=3648730

cctranscripts

March 29, 2017

Generex Biotechnology: Generex Announces $115M Convertible Preferred Stock Financing; First Tranche Satisfies Emmaus Deposit http://www.conferencecalltranscripts.org/pink/summary?id=3637897

cctranscripts

March 22, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 - Net (Loss)... http://www.conferencecalltranscripts.org/pink/summary?id=3615508

cctranscripts

March 17, 2017

Notification of inability to timely file Form 10-Q or 10-QSB http://www.conferencecalltranscripts.org/pink/summary?id=3602229

cctranscripts

March 17, 2017

Generex Biotechnology: Generex Announces Reverse Stock Split http://www.conferencecalltranscripts.org/pink/summary?id=3602336

cctranscripts

March 14, 2017

Deleted Symbol http://www.otcmarkets.com/market-activity/corpActions.jsp?index=5&symbol=GNBT&actionDate=1489467609000

cctranscripts

March 6, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3563015

cctranscripts

Feb. 24, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3528924

cctranscripts

Feb. 16, 2017

Statement of acquisition of beneficial ownership by individuals http://www.conferencecalltranscripts.org/pink/summary?id=3501244

cctranscripts

Feb. 15, 2017

Generex Biotechnology: Generex Announces Elimination Of Outstanding Derivative Securities http://www.conferencecalltranscripts.org/pink/summary?id=3496809
 


Feedback